๐Ÿงฌ GLP-1 Receptor Agonist๐Ÿ“Š ~16% Weight Loss (Phase 2)๐Ÿ”ฌ Phase 2 Completed

Ecnoglutide Tracker App

Track Every Dose. See Every Trend.

Shotlee is the free way to track your Ecnoglutide protocol from day one. Ecnoglutide is a GLP-1 receptor agonist (non-peptide approach) by XANO Pharmaceuticals / Sciwind Biosciences. Log every injection, monitor your weight trajectory, record side effects, and build a clean data history that you can review with your healthcare provider at any time.

Key Tracking Features

01

Precise dose logging with timestamps and injection site rotation

02

Visual weight and body composition trend charts over time

03

Side effect correlation to help optimize your protocol with your doctor

Clinical Snapshot

Top dose (24 wks)

~16%

Highest dose group achieved approximately 16% mean weight loss over 24 weeks in Phase 2.

Safety

Manageable

Side effect profile consistent with GLP-1 class. Generally well tolerated with dose escalation.

What This Means for Your Tracking Right Now

Whether you are already on Ecnoglutide or considering it as a future option, building clean tracking data now gives you a major advantage. Having historical weight, symptom, and dose records makes it far easier to evaluate how well any protocol is working for your body.

Use Shotlee to log your body weight trend, dose consistency, appetite changes, GI symptoms, blood pressure, and any lab markers your doctor recommends. If you ever switch medications, that historical data lets you compare outcomes with precision instead of guesswork.

Shotlee supports all major metabolic protocols today, so you can stay systematic regardless of which specific medication you are on.

Tracking Priorities in Shotlee

Weekly dose logs, side effect timing, body weight, waist measurements, and key lab snapshots are the highest-value signals to capture now in the Shotlee app.

Vital Protocol FAQs

What is Ecnoglutide?

Ecnoglutide (XW003) is a long-acting GLP-1 receptor agonist showing approximately 16% weight loss in 24-week Phase 2 trials. Track your GLP-1 protocol in the Shotlee app.

How does it compare to Semaglutide?

Both are GLP-1 agonists. Ecnoglutide's 16% loss in 24 weeks is competitive, but head-to-head data is needed. Use Shotlee to compare your own results across medications.

Start Tracking Your Protocol Today

Track your Ecnoglutide protocol with Shotlee and make every decision from clean, visible data instead of guesswork.

๐Ÿš€ Use Shotlee for Free